Is there a place for different isoforms of FSH in clinical medicine? IV. The clinician's point of view

Authors
Citation
Dt. Baird, Is there a place for different isoforms of FSH in clinical medicine? IV. The clinician's point of view, HUM REPR, 16(7), 2001, pp. 1316-1318
Citations number
25
Categorie Soggetti
Reproductive Medicine","da verificare
Journal title
HUMAN REPRODUCTION
ISSN journal
02681161 → ACNP
Volume
16
Issue
7
Year of publication
2001
Pages
1316 - 1318
Database
ISI
SICI code
0268-1161(200107)16:7<1316:ITAPFD>2.0.ZU;2-5
Abstract
Follicle stimulating hormone (FSH) plays an important role in gametogenesis in both men and women. In men it is required for the establishment and pro bably maintenance of spermatogenesis. In women it stimulates the growth of ovarian follicles and fluctuations in its secretion are involved in the sel ection of the ovulatory follicle. It is now possible by recombinant DNA tec hnology to synthesize a range of isoforms of FSH with differing biological action and half-life which would provide a greater degree of flexibility in the treatment of women with anovulatory infertility. Longer acting isoform s of FSH would find clinical application in the treatment of hypogonadotrop hic men.